On Wednesday shares of Orexigen Therapeutics, Inc. (NASDAQ:OREX) closed at $5.02. Company’s sales growth for last 5 years was 253.90% and EPS growth for next 5 years is recorded as 20.00%. Orexigen Therapeutics, Inc. (NASDAQ:OREX) and partner Takeda Pharmaceutical Company Ltd (TKPYY) announced that they have decided to terminate the Light study on their obesity drug, Contrave, following the recommendation of the Executive Steering Committee (ESC).
Sage Therapeutics, Inc. (NASDAQ:SAGE) in last trading activity moved down -1.10% to close at $57.29. Company weekly performance is 3.86% while its quarterly performance stands at 46.37%. Sage Therapeutics, Inc. (NASDAQ:SAGE) is -10.16% away from its 52 week high. SAGE Therapeutics (NASDAQ:SAGE), announced that Jeff Jonas, M.D., chief executive officer of SAGE, will present at the UBS Global Healthcare Conference at 9:30 a.m. ET on Tuesday, May 19, 2015.
On last trading day Fonar Corp. (NASDAQ:FONR) moved down -0.45% to close at $11.00. Its volatility for the week is 2.72% while volatility for the month is 2.99%. FONR’s sales growth for past 5 years was 11.50% and its EPS growth for past 5 years was 48.30%. Fonar Corp. (NASDAQ:FONR) monthly performance is -11.15%. On 11 May, Fonar Corp. (NASDAQ:FONR) reported fiscal third-quarter net income of $1.9 million. On a per-share basis, the Melville, New York-based company said it had profit of 31 cents.
Graphic Packaging Holding Company (NYSE:GPK) has 0.90% insider ownership while its institutional ownership stands at 98.50%. In last trading activity company’s stock closed at $14.66. Graphic Packaging International, Inc. (NYASE:GPK) is proud to announce that our Chairman, President and Chief Executive Officer David Scheible was named Executive Papermaker of the Year by PaperAge magazine. This has been a paper industry tradition since 1988 and is awarded based on corporate vision, strategic objectives and strong leadership both within the executive’s company and in the paper industry as a whole.
On last trading day Regional Management Corp. (NYSE:RM) moved up 0.59% to close at $17.12. Its volatility for the week is 2.40% while volatility for the month is 3.45%. RM’s sales growth for past 5 years was 23.00% and its EPS growth for past 5 years was 7.30%. Regional Management Corp. (NYSE:RM) monthly performance is 19.39%. Regional Management Corp (NYSE:RM) was upgraded by Zacks from a “sell” rating to a “strong-buy” rating in a research note issued to investors on Tuesday. The firm currently has a $20.00 target price on the stock. Zacks‘s target price would indicate a potential upside of 17.51% from the company’s current price.